Symptom improvement at 3 months with ELMIRON®
In a separate, double-blind, randomized, placebo-controlled study, 38% of patients taking ELMIRON® 300 mg/day reported at 3 months a greater than 50% improvement in bladder pain compared with 18% of patients taking placebo (N=151).§
*2499 patients received at least 1 dose of ELMIRON®.
†1192 of 2499 patients received ELMIRON® treatment for 3 months.
‡Pain scores that improved by 1 or 2 categories.
§N=128 patients in 300-mg/day group. Patient's Overall Rating of Improvement of Symptoms (PORIS) response is based on all patients, not completers.